Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2

Amanat, 2020, An in vitro microneutralization assay for SARS-CoV-2 serology and drug screening, Curr. Protoc. Microbiol., 58, e108, 10.1002/cpmc.108 Anand, 2020, High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples, bioRxiv Beaudoin-Bussières, 2020, Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals, MBio, 11, e02590-20, 10.1128/mBio.02590-20 Bergmann-Leitner, 2008, Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies, Malar. J., 7, 129, 10.1186/1475-2875-7-129 Brouwer, 2020, Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability, Science, 369, 643, 10.1126/science.abc5902 Dimitrov, 2007, Transition towards antigen-binding promiscuity of a monospecific antibody, Mol. Immunol., 44, 1854, 10.1016/j.molimm.2006.10.002 Gaebler, 2020, Evolution of antibody immunity to SARS-CoV-2, bioRxiv Grzelak, 2020, Sex differences in the decline of neutralizing antibodies to SARS-CoV-2, medRxiv Guilpain, 2020, Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia, Ann. Rheum. Dis., 80, e10, 10.1136/annrheumdis-2020-217549 Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Hughes, 2020, COVID-19 in persons with multiple sclerosis treated with ocrelizumab—a pharmacovigilance case series, Mult. Scler. Relat. Disord., 42, 102192, 10.1016/j.msard.2020.102192 Kridin, 2020, Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia, Autoimmun. Rev., 19, 102466, 10.1016/j.autrev.2020.102466 Lodge, 1997, The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells, EMBO J., 16, 695, 10.1093/emboj/16.4.695 Long, 2020, Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, Nat. Med., 26, 1200, 10.1038/s41591-020-0965-6 Looney, 2008, The effects of rituximab on immunocompetency in patients with autoimmune disease, Arthritis Rheum., 58, 5, 10.1002/art.23171 Newell, 2020, Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration, medRxiv Perera, 2020, Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020, Euro Surveill., 25, 2000421, 10.2807/1560-7917.ES.2020.25.16.2000421 Perreault, 2020, Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within four months after symptom onset, Blood, 136, 2588, 10.1182/blood.2020008367 Prévost, 2020, Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike, Cell Rep. Med., 100126, 10.1016/j.xcrm.2020.100126 Robbiani, 2020, Convergent antibody responses to SARS-CoV-2 in convalescent individuals, Nature, 584, 437, 10.1038/s41586-020-2456-9 Safavi, 2020, B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran, Mult. Scler. Relat. Disord., 43, 102195, 10.1016/j.msard.2020.102195 Schulze-Koops, 2020, Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab, Ann. Rheum. Dis. Seow, 2020, Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans, Nat. Microbiol., 5, 1598, 10.1038/s41564-020-00813-8 Sharmeen, 2020, COVID-19 in rheumatic disease patients on immunosuppressive agents, Semin. Arthritis Rheum., 50, 680, 10.1016/j.semarthrit.2020.05.010 Sormani, 2020 St-Amour, 2009, Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins, Clin. Immunol., 133, 52, 10.1016/j.clim.2009.06.005 Sterlin, 2020, Human IgA binds a diverse array of commensal bacteria, J. Exp. Med., 217, e20181635, 10.1084/jem.20181635 Wang, 2020, Enhanced SARS-CoV-2 neutralization by dimeric IgA, Sci. Transl. Med., 13, eabf1555, 10.1126/scitranslmed.abf1555 Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017